BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37292906)

  • 1. Mitochondrial citrate carrier SLC25A1 is a dosage-dependent regulator of metabolic reprogramming and morphogenesis in the developing heart.
    Ohanele C; Peoples JN; Karlstaedt A; Geiger JT; Gayle AD; Ghazal N; Sohani F; Brown ME; Davis ME; Porter GA; Faundez V; Kwong JQ
    bioRxiv; 2023 May; ():. PubMed ID: 37292906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the mitochondrial citrate carrier,
    Kasprzyk-Pawelec A; Tan M; Phua YL; Rahhal R; McIntosh A; Fernandez H; Mosaoa R; Girgis M; Cheema A; Jiang L; Kroemer LF; Popratiloff A; Clarkson C; Kirmsa BM; Pearson GW; Glasgow E; Albanese C; Vockley J; Avantaggiati ML
    bioRxiv; 2024 Feb; ():. PubMed ID: 37503155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer.
    Yang Y; He J; Zhang B; Zhang Z; Jia G; Liu S; Wu T; He X; Wang N
    Cell Death Dis; 2021 Nov; 12(12):1108. PubMed ID: 34839347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
    Chaouch A; Porcelli V; Cox D; Edvardson S; Scarcia P; De Grassi A; Pierri CL; Cossins J; Laval SH; Griffin H; Müller JS; Evangelista T; Töpf A; Abicht A; Huebner A; von der Hagen M; Bushby K; Straub V; Horvath R; Elpeleg O; Palace J; Senderek J; Beeson D; Palmieri L; Lochmüller H
    J Neuromuscul Dis; 2014; 1(1):75-90. PubMed ID: 26870663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
    Tan M; Mosaoa R; Graham GT; Kasprzyk-Pawelec A; Gadre S; Parasido E; Catalina-Rodriguez O; Foley P; Giaccone G; Cheema A; Kallakury B; Albanese C; Yi C; Avantaggiati ML
    Cell Death Differ; 2020 Jul; 27(7):2143-2157. PubMed ID: 31959914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.
    Hlouschek J; Hansel C; Jendrossek V; Matschke J
    Front Oncol; 2018; 8():170. PubMed ID: 29888201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.
    Fernandez HR; Gadre SM; Tan M; Graham GT; Mosaoa R; Ongkeko MS; Kim KA; Riggins RB; Parasido E; Petrini I; Pacini S; Cheema A; Varghese R; Ressom HW; Zhang Y; Albanese C; Üren A; Paige M; Giaccone G; Avantaggiati ML
    Cell Death Differ; 2018 Jul; 25(7):1239-1258. PubMed ID: 29651165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
    Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
    Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
    Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
    Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
    Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
    Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
    Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria.
    Nota B; Struys EA; Pop A; Jansen EE; Fernandez Ojeda MR; Kanhai WA; Kranendijk M; van Dooren SJ; Bevova MR; Sistermans EA; Nieuwint AW; Barth M; Ben-Omran T; Hoffmann GF; de Lonlay P; McDonald MT; Meberg A; Muntau AC; Nuoffer JM; Parini R; Read MH; Renneberg A; Santer R; Strahleck T; van Schaftingen E; van der Knaap MS; Jakobs C; Salomons GS
    Am J Hum Genet; 2013 Apr; 92(4):627-31. PubMed ID: 23561848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.
    Napoli E; Tassone F; Wong S; Angkustsiri K; Simon TJ; Song G; Giulivi C
    J Biol Chem; 2015 Sep; 290(38):23240-53. PubMed ID: 26221035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
    Prasun P; Young S; Salomons G; Werneke A; Jiang YH; Struys E; Paige M; Avantaggiati ML; McDonald M
    JIMD Rep; 2015; 19():111-5. PubMed ID: 25614306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse.
    Fernandez-Fuente G; Overmyer KA; Lawton AJ; Kasza I; Shapiro SL; Gallego-Muñoz P; Coon JJ; Denu JM; Alexander CM; Puglielli L
    Commun Biol; 2023 Sep; 6(1):926. PubMed ID: 37689798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved role for the mitochondrial citrate transporter Sea/SLC25A1 in the maintenance of chromosome integrity.
    Morciano P; Carrisi C; Capobianco L; Mannini L; Burgio G; Cestra G; De Benedetto GE; Corona DF; Musio A; Cenci G
    Hum Mol Genet; 2009 Nov; 18(21):4180-8. PubMed ID: 19654186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital myasthenic syndrome related to SLC25A1 gene variant: two cases report and literature review].
    Li WH; Wu BB; Zhou SZ
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):42-46. PubMed ID: 33397003
    [No Abstract]   [Full Text] [Related]  

  • 18. Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant.
    Balaraju S; Töpf A; McMacken G; Kumar VP; Pechmann A; Roper H; Vengalil S; Polavarapu K; Nashi S; Mahajan NP; Barbosa IA; Deshpande C; Taylor RW; Cossins J; Beeson D; Laurie S; Kirschner J; Horvath R; McFarland R; Nalini A; Lochmüller H
    Eur J Hum Genet; 2020 Mar; 28(3):373-377. PubMed ID: 31527857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1R-IRAKM-Slc25a1 signaling axis reprograms lipogenesis in adipocytes to promote diet-induced obesity in mice.
    Liu W; Zhou H; Wang H; Zhang Q; Zhang R; Willard B; Liu C; Kang Z; Li X; Li X
    Nat Commun; 2022 May; 13(1):2748. PubMed ID: 35585086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency.
    Smith A; McBride S; Marcadier JL; Michaud J; Al-Dirbashi OY; Schwartzentruber J; Beaulieu CL; Katz SL; ; Majewski J; Bulman DE; Geraghty MT; Harper ME; Chakraborty P; Lines MA
    JIMD Rep; 2016; 30():73-79. PubMed ID: 27306203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.